Roche goes on shopping spree
Billion euro purchase for stomach medicine
24-Oct-2023 -
(dpa-AFX) For more than seven billion U.S. dollars, the Basel-based company is buying an experimental stomach drug from the U.S. biotech company Roivant. In the deal, Roche is acquiring Telavant Holdings, a company owned by Roivant and US-based Pfizer. The deal includes development, manufacturing ...
colitis ulcerosa
Morbus Crohn
takeovers